Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.
Front Immunol
; 7: 413, 2016.
Article
in En
| MEDLINE
| ID: mdl-27777574
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Immunol
Year:
2016
Document type:
Article
Affiliation country:
Argentina
Country of publication:
Suiza